Register information Patent

DE file number : 60 2017 079 086.9 (Status: pending/in force, Query started: April 26, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTPatent
StatusSTPending/in force
21DE file number DAKZ60 2017 079 086.9
96EP file numberEAKZ21 20 7246.6
97EP publication numberEPN4019019
54Designation/titleTIVERWENDUNG VON RILUZOL, RILUZOLPRODRUGS ODER RILUZOLANALOGA MIT IMMUNTHERAPIEN ZUR BEHANDLUNG VON KREBS
51IPC main classICM
(ICMV)		 A61K 31/428 (2006.01)
51IPC secondary class(es)ICS
(ICSV)		 C07D 277/82 (2006.01), A61P 35/00 (2006.01)
22DE application dateDATMay 19, 2017
96EP application dateEATMay 19, 2017
43Date of first publicationOTJun 29, 2022
Date of publication of grantPETFeb 7, 2024
71/73Applicant/ownerINHBiohaven Therapeutics Ltd., New Haven, CT, US
72InventorINCORIC, Vladimir, New Haven, 06520, US
74RepresentativeVTRMarks & Clerk (Luxembourg) LLP, Luxembourg, LU
Address for service Marks & Clerk LLP, 1017 Luxembourg, LU
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201662339433 P
May 20, 2016
Due dateFT
FG		May 31, 2026
Annual fee for the 10th year Patent fees
Patent division in charge 44
97EP language of publicationELANGEN - Englisch
84Designated EP contracting statesEDSAL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Published EP/WO documentsEPWOPNOriginal document: EP000004019019A1
Searchable text: EP000004019019A1
Original document: EP000004019019B1
Searchable text: EP000004019019B1
43Date of first publicationEVTJun 29, 2022
Date of the first transfer into DPMAregisterEREGTJun 29, 2022
Date of the (most recent) update in DPMAregisterREGTApr 2, 2025
(Show all update days)(Hide all update days)
  • Apr 2, 2025
    • Due date: changed
  • Jan 23, 2025
    • Procedures: Procedure relating to EP application, Grant has become final, 08.11.2024: changed
  • Dec 19, 2024
    • Procedures: Procedure relating to EP application, Grant has become final, 08.11.2024: new
  • Oct 10, 2024
    • Procedures: New applicant/owner details, New applicant/owner details, 30.08.2024: changed
  • Aug 31, 2024
    • Applicant/owner: changed
    • Representative: new
    • Procedures: New applicant/owner details, New applicant/owner details, 30.08.2024: new
  • Jul 17, 2024
    • St.36: changed (technical change)
  • Jun 19, 2024; Apr 30, 2024; Feb 22, 2024; Jan 18, 2024
    • Historical data not available for this/these date(s)
  • Jun 29, 2022
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Procedure relating to EP application EPO 1st publication Jun 29, 2022  Details anzeigen
2 Publications Publication of a mention regarding EP 1st publication by DPMA Aug 11, 2022 Aug 11, 2022 Details anzeigen
3 Procedure relating to EP application EPO publication of mention regarding patent grant (beginning of opposition period) Feb 7, 2024  Details anzeigen
4 Publications Publication by DPMA of mention regarding EP patent grant Feb 22, 2024 Feb 22, 2024 Details anzeigen
5 New applicant/owner details New applicant/owner details Aug 30, 2024 Oct 10, 2024 Details anzeigen
6 Procedure relating to EP application No opposition to patent grant filed, or opposition proceedings at EPO completed without decision Nov 8, 2024 Jan 23, 2025 Details anzeigen
View procedures Procedure relating to EP application (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO 1st publication
Date of legal/procedural statusVSTTJun 29, 2022
View procedures Publications (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication of a mention regarding EP 1st publication by DPMA
Date of legal/procedural statusVSTTAug 11, 2022
Issue numberHN32
YearPJ2022
Publication dateVTAug 11, 2022
Type of publicationPARTBibliographic data
View procedures Procedure relating to EP application (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO publication of mention regarding patent grant (beginning of opposition period)
Date of legal/procedural statusVSTTFeb 7, 2024
Date of update of the procedureREGTJan 18, 2024
View procedures Publications (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication by DPMA of mention regarding EP patent grant
Date of legal/procedural statusVSTTFeb 22, 2024
Issue numberHN8
YearPJ2024
Publication dateVTFeb 22, 2024
Type of publicationPARTBibliographic data
PartHTPart 5
Date of update of the procedureREGTFeb 22, 2024
View procedures New applicant/owner details (No.: 5)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTAug 30, 2024
Issue numberHN41
YearPJ2024
Publication dateVTOct 10, 2024
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHBiohaven Therapeutics Ltd., New Haven, CT, US
71/73Previous applicant/ownerINHFBiohaven Pharmaceutical Holding Company Ltd., New Haven, CT, US
Date of update of the procedureREGTOct 10, 2024
View procedures Procedure relating to EP application (No.: 6)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTNo opposition to patent grant filed, or opposition proceedings at EPO completed without decision
Date of legal/procedural statusVSTTNov 8, 2024
Issue numberHN4
YearPJ2025
Publication dateVTJan 23, 2025
Type of publicationPARTBibliographic data
PartHTPart 3
Date of update of the procedureREGTJan 23, 2025